Tower Research Capital (TRC)’s Inhibrx, Inc. Common Stock INBX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-398
| Closed | -$13.9K | – | 6214 |
|
2024
Q1 | $13.9K | Sell |
398
-5,239
| -93% | -$183K | ﹤0.01% | 3354 |
|
2023
Q4 | $214K | Sell |
5,637
-269
| -5% | -$10.2K | ﹤0.01% | 2051 |
|
2023
Q3 | $108K | Buy |
5,906
+3,471
| +143% | +$63.7K | ﹤0.01% | 1926 |
|
2023
Q2 | $63.2K | Sell |
2,435
-3,913
| -62% | -$102K | ﹤0.01% | 2371 |
|
2023
Q1 | $120K | Buy |
6,348
+1,412
| +29% | +$26.7K | ﹤0.01% | 1699 |
|
2022
Q4 | $121K | Sell |
4,936
-717
| -13% | -$17.6K | 0.01% | 1686 |
|
2022
Q3 | $101K | Buy |
5,653
+1,115
| +25% | +$19.9K | ﹤0.01% | 2557 |
|
2022
Q2 | $52K | Buy |
4,538
+3,178
| +234% | +$36.4K | ﹤0.01% | 2851 |
|
2022
Q1 | $30K | Sell |
1,360
-808
| -37% | -$17.8K | ﹤0.01% | 3169 |
|
2021
Q4 | $95K | Buy |
2,168
+1,901
| +712% | +$83.3K | ﹤0.01% | 2264 |
|
2021
Q3 | $9K | Sell |
267
-626
| -70% | -$21.1K | ﹤0.01% | 4511 |
|
2021
Q2 | $25K | Sell |
893
-295
| -25% | -$8.26K | ﹤0.01% | 3712 |
|
2021
Q1 | $24K | Buy |
1,188
+414
| +53% | +$8.36K | ﹤0.01% | 3761 |
|
2020
Q4 | $26K | Buy |
+774
| New | +$26K | ﹤0.01% | 3711 |
|